Physician profile
Karenthea W Rouw
NPI 1003897133
$6,054.24
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.51 · 2020: $15.22 · 2021: $197 · 2022: $4,281 · 2023: $1,080 · 2024: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $738 · Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $737.80 |
| Food and Beverage | $723.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,833.82 | 2022 | |
| Foundation Medical, LLC | $1,214.85 | 2022-2024 | |
| Treace Medical Concepts, INC. | $1,057.02 | 2021-2023 | |
| Stryker Corporation | $349.35 | 2023-2024 | Ortholoc 2 Lapifuse, Prophecy, Prostep |
| Kerecis Limited | $248.80 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Gemini Medical LLC | $120.65 | 2022 | |
| Rikco International, LLC | $88.00 | 2019 | |
| Paragon 28, INC. | $40.81 | 2020-2024 | Precision Mis Bunion |
| Organogenesis INC. | $37.67 | 2022 | |
| Smith+Nephew, INC. | $32.13 | 2019-2022 | |
| Melinta Therapeutics, LLC | $17.73 | 2022 | |
| Kci USA, INC. | $13.41 | 2023 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karenthea Rouw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.